179 related articles for article (PubMed ID: 32563165)
1. Pre-treatment intravoxel incoherent motion diffusion-weighted imaging predicts treatment outcome in nasopharyngeal carcinoma.
Qamar S; King AD; Ai QH; So TY; Mo FKF; Chen W; Poon DMC; Tong M; Ma BB; Hui EP; Yeung DK; Wang YX; Yuan J
Eur J Radiol; 2020 Aug; 129():109127. PubMed ID: 32563165
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI.
Ai QY; King AD; Chan JSM; Chen W; Chan KCA; Woo JKS; Zee BCY; Chan ATC; Poon DMC; Ma BBY; Hui EP; Ahuja AT; Vlantis AC; Yuan J
Eur Radiol; 2019 Oct; 29(10):5627-5634. PubMed ID: 30903340
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
Qamar S; King AD; Ai QH; Mo FKF; Chen W; Poon DMC; Tong M; Ma BB; Yeung DK; Wang YX; Yuan J
Eur Radiol; 2020 Nov; 30(11):6339-6347. PubMed ID: 32588210
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal carcinoma: comparison of diffusion and perfusion characteristics between different tumour stages using intravoxel incoherent motion MR imaging.
Lai V; Li X; Lee VH; Lam KO; Fong DY; Huang B; Chan Q; Khong PL
Eur Radiol; 2014 Jan; 24(1):176-83. PubMed ID: 23990005
[TBL] [Abstract][Full Text] [Related]
5. Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.
Hou J; Yu X; Hu Y; Li F; Xiang W; Wang L; Wang H; Lu Q; Zhang Z; Zeng W
Medicine (Baltimore); 2016 Aug; 95(35):e4320. PubMed ID: 27583847
[TBL] [Abstract][Full Text] [Related]
6. Predicting chemoradiotherapy response of nasopharyngeal carcinoma using texture features based on intravoxel incoherent motion diffusion-weighted imaging.
Qin Y; Yu X; Hou J; Hu Y; Li F; Wen L; Lu Q; Fu Y; Liu S
Medicine (Baltimore); 2018 Jul; 97(30):e11676. PubMed ID: 30045324
[TBL] [Abstract][Full Text] [Related]
7. The value of intravoxel incoherent motion model-based diffusion-weighted imaging for predicting long-term outcomes in nasopharyngeal carcinoma.
Qin Y; Chen C; Chen H; Gao F
Front Oncol; 2022; 12():902819. PubMed ID: 36531009
[TBL] [Abstract][Full Text] [Related]
8. Investigating the value of arterial spin labeling and intravoxel incoherent motion imaging on diagnosing nasopharyngeal carcinoma in T1 stage.
Li Y; Li X; Yu X; Lin M; Ouyang H; Xie L; Shang Y
Cancer Imaging; 2020 Aug; 20(1):62. PubMed ID: 32859273
[TBL] [Abstract][Full Text] [Related]
9. Intravoxel incoherent motion MRI: emerging applications for nasopharyngeal carcinoma at the primary site.
Zhang SX; Jia QJ; Zhang ZP; Liang CH; Chen WB; Qiu QH; Li H
Eur Radiol; 2014 Aug; 24(8):1998-2004. PubMed ID: 24838795
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
[TBL] [Abstract][Full Text] [Related]
11. Intravoxel incoherent motion diffusion-weighted imaging for discrimination of benign and malignant retropharyngeal nodes.
So TY; Ai QH; Lam WKJ; Qamar S; Poon DMC; Hui EP; Mo FKF; Chan KCA; King AD
Neuroradiology; 2020 Dec; 62(12):1667-1676. PubMed ID: 32676831
[TBL] [Abstract][Full Text] [Related]
12. Intravoxel incoherent motion MR imaging: comparison of diffusion and perfusion characteristics between nasopharyngeal carcinoma and post-chemoradiation fibrosis.
Lai V; Li X; Lee VH; Lam KO; Chan Q; Khong PL
Eur Radiol; 2013 Oct; 23(10):2793-801. PubMed ID: 23722897
[TBL] [Abstract][Full Text] [Related]
13. Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imaging.
Zhou N; Chu C; Dou X; Li M; Liu S; Zhu L; Liu B; Guo T; Chen W; He J; Yan J; Zhou Z; Yang X; Liu T
BMC Cancer; 2016 Nov; 16(1):865. PubMed ID: 27821130
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Assessment of Intravoxel Incoherent Motion Diffusion Weighted Imaging in Evaluating the Radio-sensitivity of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy.
Xiao Y; Chen Y; Chen Y; He Z; Yao Y; Pan J
Cancer Res Treat; 2019 Jan; 51(1):345-356. PubMed ID: 29764118
[TBL] [Abstract][Full Text] [Related]
15. Intravoxel incoherent motion MRI in differentiation between recurrent carcinoma and postchemoradiation fibrosis of the skull base in patients with nasopharyngeal carcinoma.
Mao J; Shen J; Yang Q; Yu T; Duan X; Zhong J; Phuyal P; Liang B
J Magn Reson Imaging; 2016 Dec; 44(6):1556-1564. PubMed ID: 27227674
[TBL] [Abstract][Full Text] [Related]
16. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
[TBL] [Abstract][Full Text] [Related]
17. Initial experience of correlating parameters of intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging at 3.0 T in nasopharyngeal carcinoma.
Jia QJ; Zhang SX; Chen WB; Liang L; Zhou ZG; Qiu QH; Liu ZY; Zeng QX; Liang CH
Eur Radiol; 2014 Dec; 24(12):3076-87. PubMed ID: 25052079
[TBL] [Abstract][Full Text] [Related]
18. Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma.
Xiao-ping Y; Jing H; Fei-ping L; Yin H; Qiang L; Lanlan W; Wei W
J Magn Reson Imaging; 2016 May; 43(5):1179-90. PubMed ID: 26540374
[TBL] [Abstract][Full Text] [Related]
19. Intravoxel Incoherent Motion Diffusion Weighted Magnetic Resonance Imaging for Differentiation Between Nasopharyngeal Carcinoma and Lymphoma at the Primary Site.
Yu XP; Hou J; Li FP; Wang H; Hu PS; Bi F; Wang W
J Comput Assist Tomogr; 2016; 40(3):413-8. PubMed ID: 26953769
[TBL] [Abstract][Full Text] [Related]
20. Intravoxel Incoherent Motion-Magnetic Resonance Imaging as an Early Predictor of Treatment Response to Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
Xiao Y; Pan J; Chen Y; Chen Y; He Z; Zheng X
Medicine (Baltimore); 2015 Jun; 94(24):e973. PubMed ID: 26091468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
